Intrathecal somatostatin in terminally ill patients. A report of two cases.
Intrathecal morphine has been shown to be reliable in producing analgesia in patients with intractable cancer pain. Recently, we have demonstrated that intrathecal somatostatin is as effective in the treatment of cancer pain as intrathecal morphine. This report presents 2 cases in whom analgesia could be maintained for 60 and 25 days, respectively, under continuous intrathecal infusion of somatostatin by means of infusion devices.
Meynadier
J
J
Department of Anaesthesia, Centre Oscar Lambret, 59020 LilleFrance Department of Anaesthesia, University Hospital, FreiburgF.R.G. Max Planck Institute of Biochemistry, MunichF.R.G.
Chrubasik
J
J
Dubar
M
M
Wünsch
E
E
D000368:Aged; D006801:Humans; D008297:Male; D008875:Middle Aged; D010148:Intractable Pain / Q000188:drug therapy*; D013004:Somatostatin / Q000008:administration & dosage* / Q000627:therapeutic use; D013727:Terminal Care
D013004:Somatostatin